Skip to content

Practical continuation of a screening-based geriatric oncology treatment and intervention (GOBI II) in vulnerable elderly cancer patients, who require outpatient system oncology or radiotherapy treatment: A monocentric 2:1 randomized intervention trial

Practical continuation of a screening-based geriatric oncology treatment and intervention (GOBI II) in vulnerable elderly cancer patients, who require outpatient system oncology or radiotherapy treatment: A monocentric 2:1 randomized intervention trial - GOBI II (geriatric-oncologic treatment and intervention)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037591
Enrollment
300
Registered
2025-08-05
Start date
2025-08-18
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C79 C50

Interventions

Group 1: Intervention: Practical Geriatric Assessment (PGA) and multi-disciplinary geriatric co-management and intervention (geriatric physiotherapy, occupational therapy, nutritional counseling, psyc

Sponsors

CCC Mainfranken Universitätsklinikum Würzburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to No maximum

Inclusion criteria

Inclusion criteria: Written informed consent, =70-year-old tumor patients receiving outpatient oncological/radiotherapeutic treatment. Patients must always be able to follow a recommended intervention (e.g. physiotherapy, nutritional advice, etc.).

Exclusion criteria

Exclusion criteria: lack of linguistic understanding Guardianship, Dementia, the presence of multiple malignancies is explicitly not a reason for exclusion.

Design outcomes

Primary

MeasureTime frame
Proof of effect of a practical geriatric assessment and individual multidisciplinary intervention in the T2 (12 weeks) variables IADL=8 and EORTC QLQ-C30 QOL scale

Secondary

MeasureTime frame
Description of the T2 variable CTC AE >/= Grade 3, which occur between T1 and T2 therapy-associated.

Countries

Germany

Contacts

Public ContactBarbara Deschler- Baier

UKW CCC Mainfranken

deschler_b@ukw.de+4993120135060

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026